Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 27;46(10):10846-10853.
doi: 10.3390/cimb46100644.

Exploring miRNA Biomarkers in Major Depressive Disorder: A Molecular Medicine Perspective

Affiliations

Exploring miRNA Biomarkers in Major Depressive Disorder: A Molecular Medicine Perspective

Cătălin Prodan-Bărbulescu et al. Curr Issues Mol Biol. .

Abstract

Major depressive disorder (MDD) is a complex mental health condition with a multifaceted and incompletely elucidated pathophysiology. MicroRNAs (miRNAs) have emerged as potential biomarkers due to their role in gene regulation and the observed dysregulation in MDD. The aim of this study is to detect the presence of specific molecular diagnostic biomarkers in major depressive disorder. This cross-sectional study analyzed plasma miRNA expression in ten MDD patients and eight healthy controls using real-time PCR. Differentially expressed miRNAs were identified using independent t-tests, and their diagnostic potential was assessed with ROC curve analysis. Fifteen miRNAs exhibited significant dysregulation in MDD patients. Notably, hsa-miR-29c-3p, hsa-miR-376a-3p, hsa-miR-532-5p, and hsa-miR-339-5p showed excellent discriminatory power (AUC > 0.8). This study identifies differentially expressed plasma miRNAs in MDD, suggesting their potential for improved diagnosis and personalized treatment. However, further validation in larger cohorts and investigation into their functional roles are warranted.

Keywords: depression; major depressive disorder; miRNA; miRNA dysregulation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Overview of the trajectory of this study.

References

    1. Fries G.R., Zhang W., Benevenuto D., Quevedo J. MicroRNAs in Major Depressive Disorder. In: Guest P.C., editor. Reviews on Biomarker Studies in Psychiatric and Neurodegenerative Disorders. Volume 1118. Springer International Publishing; Cham, Switzerland: 2019. pp. 175–190. Advances in Experimental Medicine and Biology. - PubMed
    1. Navneet Bain S.A. StatPearls [Internet] StatPearls Publishing; Treasure Island, FL, USA: 2024. [(accessed on 18 September 2023)]. Major Depressive Disorder. Available online: https://www.ncbi.nlm.nih.gov/books/NBK559078/
    1. Marx W., Penninx B.W.J.H., Solmi M., Furukawa T.A., Firth J., Carvalho A.F., Berk M. Major Depressive Disorder. Nat. Rev. Dis. Primer. 2023;9:44. doi: 10.1038/s41572-023-00454-1. - DOI - PubMed
    1. Otte C., Gold S.M., Penninx B.W., Pariante C.M., Etkin A., Fava M., Mohr D.C., Schatzberg A.F. Major Depressive Disorder. Nat. Rev. Dis. Primer. 2016;2:16065. doi: 10.1038/nrdp.2016.65. - DOI - PubMed
    1. Chand SP A.H. StatPearls [Internet] StatPearls Publishing; Treasure Island, FL, USA: 2024. Depression.

LinkOut - more resources